Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant

NCT02389517 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Plasma Cell Myeloma
Residual Disease

Interventions

DRUG: Ixazomib Citrate
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

University of Chicago

Collaborators

[object Object]
[object Object]